$46.24
0.992.19%
At close: -
$46.24
0.000500.00%
After Hours: Dec 20, 4:01 PM EDT
PTC Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of PTC Therapeutics using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-11-07 | $-1.39 | $-1.44 | 3.47 % |
Jun 2024 | 2024-08-08 | $-1.29 | $-1.05 | -22.9 % |
Mar 2024 | 2024-04-25 | $-1.20 | $-1.24 | 3.23 % |
Dec 2023 | 2024-02-29 | $-0.24 | $0.50 | -148.0 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-11-07 | $196.79M | $172.65M | 14.0 % |
Jun 2024 | 2024-08-08 | $186.70M | $185.87M | 0.45 % |
Mar 2024 | 2024-04-25 | $210.12M | $169.70M | 23.8 % |
Dec 2023 | 2024-02-29 | $307.06M | $321.29M | -4.43 % |
PTC Therapeutics (PTCT) is scheduled to report earnings on February 27, 2025. The last reported earnings were for reported on November 7, 2024 for Q3.
The Actual EPS was $-1.39, which beat the estimate of $-1.44.
The Actual Revenue was $196.8M, which beat the estimate of $172.7M.
Browse earnings estimates, EPS, and revenue on all stocks.